Press Release – Jamaica: Rose Hill Apothecary Executes First Major International Export Deal, Supplying Research-Grade Psilocybin to Brazil | Cannabis Law Report | Where to buy Skittles Moonrock online

Learn where to buy weed online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

RUNAWAY BAY, Jamaica, June 13, 2025 (GLOBE NEWSWIRE) — Rose Hill Apothecary (“The Company” or “Rose Hill”), a global leader in the research and intellectual property of premium psilocybin products, today announced the successful execution of its first major international export agreement, marking a significant milestone in the global advancement of regulated psychedelic medicine. The company has exported 18 kilograms of dried, psilocybin-containing mushrooms to Biocase Brasil Importação e Comércio de Medicamentos Ltda (Biocase Brasil) for use in medicinal research and development initiatives under Brazil’s regulatory framework.

All exported materials meet stringent Certificate of Analysis (COA) standards, with comprehensive testing conducted by ACS Laboratory in Florida. Tests covered potency, heavy metals, pesticides, and microbiological safety, underscoring Rose Hill’s commitment to quality and compliance in the emerging psychedelics sector.

“This landmark agreement is a testament to Rose Hill’s operational capabilities, unwavering commitment to quality, and our vision to become a trusted global partner in the advancement of psychedelic therapies,” said Domenic Suppa, Chief Operating Officer of Rose Hill Apothecary. “By facilitating access to standardized, research-grade psilocybin, we are supporting critical efforts to unlock new treatments for mental health conditions around the world.”

The agreement with Biocase Brasil not only validates Rose Hill’s compliance with evolving international regulatory standards but also demonstrates its ability to reliably supply legal, research-grade psilocybin to partners around the globe. It represents a key step forward in Rose Hill’s broader mission of accelerating mental health research and widening access to safe, effective psychedelic compounds.

“This milestone highlights the depth of expertise that Rose Hill brings to the global psychedelics industry,” said Charles Lazarus, Chief Executive Officer of Rose Hill Apothecary. “From precision cultivation to rigorous testing and international regulatory navigation, our team is setting a new standard for the safe, reliable supply of research-grade psilocybin. We’re proud to help drive the next generation of mental health innovation and to expand the reach of responsible, science-backed psychedelic therapies worldwide.”

The announcement comes as global interest in the therapeutic potential of psychedelics continues to surge, with pharmaceutical companies, investors, and research institutions increasingly seeking reliable, compliant suppliers of these critical materials.